register

News & Trends - Medical Technology

Homegrown medtech to expand its footprint

Health Industry Hub | June 14, 2022 |
[Total: 1    Average: 4/5]

MedTech News: The government will give a multi-million-dollar tax break and infrastructure subsidy to the homegrown medtech to expand and modernise its advanced manufacturing facility in Sydney’s Lane Cove, cementing the facility’s critical role in Cochlear’s global manufacturing network for the next ten years.

Premier Dominic Perrottet said the investment in Cochlear would boost high-skilled advanced manufacturing jobs in NSW.

“Cochlear is a fantastic Australian success story and we are proud to support NSW expansion that will enable improvements to the innovation it delivers across the globe,” Mr Perrottet said.

“The company is a prime example of a thriving, R&D driven business, with more than 95% of its revenue coming through its exports to more than 180 countries.

“Choosing to retain and expand here in NSW is a clear signal of our state strength in the MedTech manufacturing industry and I am delighted that the support will enable the company to build the highly-skilled workforce it needs to meet the global demand for its products.”

Minister for Enterprise, Investment and Trade Stuart Ayres said the Jobs Plus Program support, including payroll tax exemptions, would create 175 jobs by 2024.

“This investment will strengthen NSW’s advanced medical technology manufacturing capability and create ongoing positions, to enable a pipeline of skilled workers,” Mr Ayres said.

“NSW businesses make up almost 55 per cent of Australia’s estimated $6.1 billion medical technology industry and we want to support and accelerate the growth of the sector to create jobs through life-enhancing medical innovations.

“This support will also enhance our local research and development capabilities, with Cochlear investing more than $100 million in Australia every year to better understand and treat hearing loss.”

Cochlear CEO and President Dig Howitt said the Jobs Plus Program played a central role in deciding to revitalise its advanced manufacturing capacity at Lane Cove.

“Cochlear was founded more than 40 years ago and our site at Lane Cove was our first global headquarters and manufacturing facility. With Jobs Plus support, the facility that made our first hearing implants will be making our next generation implants 40 years later,” Mr Howitt said.

“Cochlear is part of a thriving medical technology and hearing health ecosystem in NSW that brings significant economic and health benefits to our community. The Jobs Plus Program is backing a sector that will only grow in value over the coming decade.”


Human Resources

Only 29% of employees say their leader shows ‘human leadership’

Health Industry Hub | June 24, 2022 |

Human Resources: A survey of more than 230 HR leaders revealed that 90% believe that to succeed in today’s work environment, […]

More


News & Trends - Medical Technology

MedTech News - Quantum HealthCare appointed as ANZ distributor for new medical technology

Quantum HealthCare appointed as ANZ distributor for new medical technology

Health Industry Hub | June 24, 2022 |

MedTech News: Alfred Health Hospital in Australia is set to receive first-in-nation portable MRI systems for point-of-care brain scans. US-based […]

More


News & Trends - Medical Technology

Medtech News - Medical association continues its strong opposition to Honeysuckle Health in legal proceedings

Medical association continues its strong opposition to Honeysuckle Health in legal proceedings

Health Industry Hub | June 24, 2022 |

MedTech News: The Australian Medical Association (AMA) is involved in proceedings before the Australian Competition Tribunal, opposing an attempt by […]

More


News & Trends - Medical Technology

Medtech News -

Medtronic award winner secures approval in diagnosis of gut disorders

Health Industry Hub | June 24, 2022 |

MedTech News: New Zealand based company and winner of the inaugural Medtronic APAC Innovation Challenge (MAIC) has received FDA approval […]

More


This content is copyright protected